The costs of bipolar disorder in the United Kingdom

Abstract

Objectives: To estimate the individual cost and population-level economic burden of Bipolar Disorder (BD), and explore the impact of clinical and sociodemographic factors on costs in the United Kingdom.Methods: Annual UK health care, social care and societal cost data were collected from a prospective cohort of 91 BD patients using digital monitoring of symptoms. Costs (in £) were calculated for the year of resource use collection (2010)(2011) and main results inflated to year 2018-2019. A Generalized Estimating Equation framework was used to investigate individual factors influencing costs. An economic burden estimate was derived by multiplying the mean annual cost per patient with literature-based population prevalence. Results:The average annual cost of BD per patient was £12,617 (SE = ±£1085) or £14,938 (SE = ±£1281) at 2018-2019 prices with 68% of the total costs attributed to lost productivity and informal care, 31% to health care costs, 1% to private outof-pocket expenses, and 0.5% to social care costs. A unit increase in average levels of depressive or manic symptoms were associated with 7% and 11% higher societal costs, respectively. The estimated annual prevalence of BD in the United Kingdom was 0.8% resulting in a population-level economic burden estimate of £5.1 billion for 2010-2011 or £6.43 billion for 2018-2019.Conclusions: BD is a disease of substantial costs in the United Kingdom with the majority of the economic burden falling outside the health care system in the form of productivity losses and informal care. These costs highly correlate with patient outcomes highlighting further needs for improved treatment efforts into functionality.

The association between childhood bullying victimisation and childhood maltreatment with the clinical expression of bipolar disorder

“…Moreover, BD has one of the highest rates of suicide attempts (up to 60%) and death by suicide (up to 19%) of all psychiatric illnesses (Dome et al, 2019). It is clear that a worse clinical expression of BD is associated with substantial costs to the individual and wider society through a significant reduction in quality of life and increased utilisation of health services (Michalak et al, 2006;Simon et al, 2021). Elucidation of factors that influence the BD clinical expression is of great clinical importance to devise effective interventions.…”

A Meta-Analysis of Group Cognitive Behavioral Therapy and Group Psychoeducation for Treating Symptoms and Preventing Relapse in People Living with Bipolar Disorder

“…It is evident that bipolar disorder has a significant impact on one’s cognition, function, and quality of life. In addition, bipolar disorder affects the quality of life of caregivers and family members, not to mention the burden on healthcare systems in terms of resources and costs around the world [ 4 , 5 ]. The impact of bipolar disorder is far-reaching.…”

Caring for a Family Member with Psychosis or Bipolar Disorder Who Has Experienced Suicidal Behaviour: An Exploratory Qualitative Study of an Online Peer-Support Forum

“…In the UK, healthcare policy explicitly recognises the value of this support by committing to develop the best practices for carer recognition and assistance as part of the National Health Service Long Term Plan [ 2 ]. Yet while community support for people experiencing mental health problems relieves considerable strain on national financial resources, it is often provided at significant personal cost to the carer [ 3 , 4 ]. Carers of people with psychosis and bipolar disorder consistently report high levels of distress, negative financial impacts, and limited access to social resources [ 5 , 6 ].…”